{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Eradicating Hepatitis C Virus: The APRN's Role

Activity Steps

Purpose of Activity

To provide information that supports the APRN's role in the eradication of hepatitis C virus (HCV).

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize the demographics of HCV infection indicating high risk populations.
  2. Examine methods of screening and diagnosing hepatitis C virus.
  3. Identify treatment regimens for hepatitis C virus and implications for patient education.
Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.0 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: NP1119B
Published: Nov 2019
Expires: 12/6/2024
Required Passing Score: 13/18 (72%)
Authors: Renee Pozza, PhD, RN, FNP-BC, FAASLD; Catherine McCoy-Hill, DNP, CCRN, ANP; Katherine Hall, PhD, RN, FNP-BC; Anna Hefner, PhD, RN, CPNP; Kimberly Wilgers, BS, CMA; Julia Tapelband, BS, EMT; Momin Masroor, BS, EMT; Tarek Hassanein, MD, FACP, FACG, AGAF, FAASLD